Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Diuraven** is an AVN Ayurveda Formulations proprietary Ayurvedic multi-herb tablet formulation marketed for urinary-tract and renal complaints, including urinary tract infection and inflammation, renal calculi, and oedema. AVN also positions it as an adjunct to standard care for hypertension and for oedema associated with musculoskeletal inflammatory conditions such as arthritis, gout, myositis, and blunt-force trauma. The product family contains botanical ingredients including gokshura (*Tribulus terrestris*), guggulu (*Commiphora mukul*), triphala components, ginger, black pepper, long pepper, musta, and punarnava; AVN attributes diuretic, anti-inflammatory, and antioxidant effects to the formulation. Diuraven D.S. is a separately marketed double-strength tablet presentation and is not treated as a synonym for regular-strength Diuraven.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Diuraven.